Release Date: 14/10/15 12:40 Summary: Cancel - Return of Capital - TYO Price Sensitive: No Download Document 24.76KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%